Patent details

EP2405002 Title: Compositions and methods for oligonucleotide formulations

Basic Information

Publication number:
EP2405002
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP111838579
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Compositions and methods for oligonucleotide formulations
French Title of Invention:
Compositions et procédés pour formulations d'oligonucléotides
German Title of Invention:
Zusammensetzungen und Verfahren für Oligonucleotidformulierungen
SPC Number:

Dates

Filing date:
15/02/2007
Grant date:
24/09/2014
EP Publication Date:
24/09/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/01/2012
EP B1 Publication Date:
24/09/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/02/2015
Expiration date:
15/02/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/02/2007
 
 

Name:
AdiuTide Pharmaceuticals GmbH
Address:
Alt Fechenheim 34, 60386 Frankfurt am Main, Germany (DE)

Inventor

1

Name:
Noll Bernhard
Address:
Germany (DE)

2

Name:
Uhlmann Eugen
Address:
Germany (DE)

3

Name:
Vollmer Joerg
Address:
Germany (DE)

4

Name:
Krieg Arthur M.
Address:
United States (US)

5

Name:
Samulowitz Ulrike
Address:
Germany (DE)

Priority

1

Priority Number:
773505 P
Priority Date:
15/02/2006
Priority Country:
United States (US)

2

Priority Number:
858240 P
Priority Date:
09/11/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 15/117;
Filing date Document type Number of pages